Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:238-245
Published online before print July 10, 2003, doi: 10.1161/01.RES.0000085580.45279.60
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v95,pe34)
Right arrow All Versions of this Article:
93/3/238    most recent
01.RES.0000085580.45279.60v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Lee, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Lee, R. T.
Related Collections
Right arrow Other myocardial biology
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
(Circulation Research. 2003;93:238.)
© 2003 American Heart Association, Inc.


Integrative Physiology

Effect of a Cleavage-Resistant Collagen Mutation on Left Ventricular Remodeling

Merry L. Lindsey*, Jun Yoshioka*, Catherine MacGillivray, Suphichaya Muangman, Joseph Gannon, Anjali Verghese, Masanori Aikawa, Peter Libby, Stephen M. Krane, Richard T. Lee

From the Leducq Center for Cardiovascular Research, Cardiovascular Division (M.L.L., J.Y., C.M., S.M., J.G., A.V., M.A., P.L., R.T.L.), Department of Medicine, Brigham and Women’s Hospital, and the Department of Medicine, Massachusetts General Hospital (S.M.K.), Harvard Medical School, Boston, Mass.

Correspondence to Richard T. Lee, MD, Cardiovascular Division, Partners Research Facility, Room 279, 65 Landsdowne St, Cambridge, MA 02139. E-mail rlee{at}rics.bwh.harvard.edu

Matrix metalloproteinase–mediated degradation of type I collagen may play a role in cardiac remodeling after strain or injury. To explore this hypothesis, we used mice homozygous (r/r) for a targeted mutation in Col1a1; these mice synthesize collagen I that resists collagenase cleavage at Gly975-Leu976. A total of 64 r/r and 84 littermate wild-type mice (WT) underwent experimental pressure overload by transverse aortic constriction (TAC) or myocardial infarction (MI). Echocardiographic, hemodynamic, and histological parameters were evaluated up to 12 weeks after TAC or 21 days after MI. At 4 weeks after TAC, collagen levels, wall thickness, and echocardiographic parameters were similar in the 2 groups. At 12 weeks after TAC, r/r mice had smaller LV dimensions (ESD: 2.7±0.2 mm WT versus 1.7±0.2 mm r/r, P<0.013; EDD: 3.8±0.2 mm WT versus 3.1±0.1 mm r/r, P<0.013); better fractional shortening (30±2% WT versus 46±4% r/r; P<0.013); and lower LV/body weight ratios (7.3±0.6 WT and 5.1±0.5 r/r; P<0.013). Surprisingly, these differences were not accompanied by differences in collagen accumulation, myocyte cross-sectional areas, wall thickness, or microvessel densities. Furthermore, no differences in LV remodeling assessed by echocardiography, fibrosis, or hemodynamic parameters were found between r/r and WT mice after MI. Thus, a mutation that encodes a collagenase cleavage-resistant collagen I does not affect early LV remodeling after TAC or MI, suggesting that collagen cleavage at this site is not the mechanism by which metalloproteinases mediate LV remodeling. Collagen cleavage could, however, have a role in preservation of cardiac function in late remodeling by mechanisms independent of collagen accumulation. We were not able to detect collagen cleavage fragments, and could not, therefore, rule out the possibility of collagen cleavage at additional sites.


Key Words: matrix metalloproteinases • collagen • left ventricular remodeling • myocardial infarction




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Sartoretto, B. Y. Jin, M. Bauer, F. B. Gertler, R. Liao, and T. Michel
Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1697 - H1710.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. Wang, K. Deng, S. Zaremba, X. Deng, C. Lin, Q. Wang, M. L. Tortorello, and W. Zhang
Transcriptomic Response of Escherichia coli O157:H7 to Oxidative Stress
Appl. Envir. Microbiol., October 1, 2009; 75(19): 6110 - 6123.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al.
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H232 - H239.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Yoshioka, R. N. Prince, H. Huang, S. B. Perkins, F. U. Cruz, C. MacGillivray, D. A. Lauffenburger, and R. T. Lee
Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine/paracrine heparin-binding EGF
PNAS, July 26, 2005; 102(30): 10622 - 10627.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. C. Schulze and R. T. Lee
Macrophage-Mediated Cardiac Fibrosis
Circ. Res., September 17, 2004; 95(6): 552 - 553.
[Full Text] [PDF]